BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamaga LYI, Wagner J, Funari MBDG. 68Ga-DOTATATE PET/CT in Nonneuroendocrine Tumors: A Pictorial Essay. Clinical Nuclear Medicine 2017;42:e313-6. [DOI: 10.1097/rlu.0000000000001620] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Alabed YZ. 68Ga-DOTATATE PET/CT Incidentally Detects Relapsed Chronic Lymphocytic Leukemia in Patient With Metastatic Neuroendocrine Tumor. Clin Nucl Med 2023;48:e78-9. [PMID: 36607378 DOI: 10.1097/RLU.0000000000004386] [Reference Citation Analysis]
2 Song H, Guja KE, Yang EJ, Guo HH. 64Cu-DOTATATE Uptake in a Pulmonary Hamartoma. Clin Nucl Med 2023;48:58-60. [DOI: 10.1097/rlu.0000000000004390] [Reference Citation Analysis]
3 Zhang B, He Q, Long Y, Zhang Y, Wang X, Chen Z, Liu J, Zhang X. Comparison of diagnostic efficacy of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT in ectopic adrenocorticotropic hormone syndrome. Front Endocrinol 2022;13:962800. [DOI: 10.3389/fendo.2022.962800] [Reference Citation Analysis]
4 Bentestuen M, Gossili F, Almasi CE, Zacho HD. Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT: a systematic review of the literature. Cancer Imaging 2022;22:44. [PMID: 36057635 DOI: 10.1186/s40644-022-00484-0] [Reference Citation Analysis]
5 Koopmans KP, Brouwers AH. Imaging Brain Metastases of Neuroendocrine Tumors. PET and SPECT in Neurology 2021. [DOI: 10.1007/978-3-030-53168-3_42] [Reference Citation Analysis]
6 Laffi A, Fazio N, Rubino M, Spada F. Mixed Neuroendocrine and Non-neuroendocrine Neoplasms (Mi NEN). Neuroendocrine Neoplasia Management 2021. [DOI: 10.1007/978-3-030-72830-4_18] [Reference Citation Analysis]
7 Ambinder EB, Werner RA, Rowe SP. Incidental primary breast cancer detected on surveillance 68Ga-DOTATATE PET/CT in a patient with metastatic neuroendocrine carcinoma. Radiol Case Rep 2020;15:1344-7. [PMID: 32617128 DOI: 10.1016/j.radcr.2020.05.054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Rahman WT, Neal CH, Nees AV, Brown RKJ. Management of Incidental Breast Lesions Detected at Nuclear Medicine Examinations. Radiol Imaging Cancer 2020;2:e190037. [PMID: 33778704 DOI: 10.1148/rycan.2020190037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Werner RA, Thackeray JT, Pomper MG, Bengel FM, Gorin MA, Derlin T, Rowe SP. Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CT. J Clin Med 2019;8:E1060. [PMID: 31331016 DOI: 10.3390/jcm8071060] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
10 Grazia Giancipoli R, Khattar P, Bodei L. Two Abdominal Masses Detected With (68)Ga-DOTATATE PET/CT in a Patient With Necrolytic Migratory Erythema. Gastroenterology 2018;155:e11-3. [PMID: 29883581 DOI: 10.1053/j.gastro.2018.05.045] [Reference Citation Analysis]
11 Werner RA, Bundschuh RA, Bundschuh L, Javadi MS, Higuchi T, Weich A, Sheikhbahaei S, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Lapa C, Rowe SP. Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications. Ann Nucl Med 2018;32:512-22. [PMID: 30109562 DOI: 10.1007/s12149-018-1291-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
12 Lee L, Ito T, Jensen RT. Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies. Expert Rev Anticancer Ther 2018;18:837-60. [PMID: 29973077 DOI: 10.1080/14737140.2018.1496822] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 8.4] [Reference Citation Analysis]
13 Pulmonary Carcinoid Tumor. Specialty Imaging: PET 2018. [DOI: 10.1016/b978-0-323-52484-1.50045-5] [Reference Citation Analysis]